Top of the morning to you. The sun is shining brightly over the Pharmalot corporate campus and another lovely day appears to be unfolding. To celebrate, we are brewing a delicious cup of stimulation - Cinnamon Cream Swirl is our pick this time. Feel free to join us, or at least grab a bottle of water. Meanwhile, though, there is much to do. As usual, we are behind in our reading and our to-do list is growing quite long. We trust you can relate. So no need to dilly dally. Here are some items of interest. Have a productive day and drop us a line if you hear something interesting...
Bristol-Myers Still Hopes Gilead Will Test Hep C Combo (Reuters)
US House Passes PDUFA Bill (Bloomberg News)
Glaxo Considers Replacing Human Genome Board (Reuters)
Medivation And The Buzz About Its Prostate Cancer Drug (Xconomy)
Pfizer Wins Another Prempro Breast Cancer Case (Bloomberg News)
CVS Pushes Back Against Co-Pay Cards, Again (Dow Jones)
Rise In US Health Costs May Be Slowing (Bloomberg News)
Icahn Takes Another Run At Forest Labs (Reuters)
Bayer And Covance Form Partnership For Drug Development (Pharma Times)
Insurers Boosting Patient Costs For Specialty Meds (Los Angeles Times)
A Blood Test For Detecting Breast Cancer Years In Advance (Daily Telegraph)
Cardiologists Debate Which Bloodthinner To Choose (Wall Street Journal)
Brazil And China Pharma Marketing Spending Rises (Pharma Times)
Foundation Medicine DNA Test For Picking Cancer Drugs (Forbes)
UCB Takes Majority Stake In Brazil's Meizler Biopharma (Pharma Times)
EDITOR'S NOTE: Please check this post for updates during the day
steaming coffee pic thx to dleggett on flickr